Related references
Note: Only part of the references are listed.Bilirubin: The yellow hormone?
Libor Vitek et al.
JOURNAL OF HEPATOLOGY (2021)
Association of Serum Bilirubin Level with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study of 1672 Obese Children
Cristina Bellarosa et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Circulating total bilirubin and risk of non-alcoholic fatty liver disease in the PREVEND study: observational findings and a Mendelian randomization study
Setor K. Kunutsor et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2020)
Bilirubin as a signaling molecule
Libor Vitek
MEDICINAL RESEARCH REVIEWS (2020)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Genetically Regulated Bilirubin and Risk of Non-alcoholic Fatty Liver Disease: A Mendelian Randomization Study
Lei Luo et al.
FRONTIERS IN GENETICS (2018)
Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases
Karl-Heinz Wagner et al.
CLINICAL SCIENCE (2015)
Noninvasive estimation of disease activity and liver fibrosis in nonalcoholic fatty liver disease using anthropometric and biochemical characteristics, including insulin, insulin resistance, and 13C-methionine breath test
Huseyin Korkmaz et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2015)
Heme oxygenase-1 gene promoter polymorphism and the risk of pediatric nonalcoholic fatty liver disease
P-F Chang et al.
INTERNATIONAL JOURNAL OF OBESITY (2015)
A non-invasive prediction model for non-alcoholic steatohepatitis in paediatric patients with non-alcoholic fatty liver disease
Katharine Eng et al.
DIGESTIVE AND LIVER DISEASE (2014)
被撤回的出版物: Increased HO-1 Levels Ameliorate Fatty Liver Development Through a Reduction of Heme and Recruitment of FGF21 (Retracted article. See FEB, 2023)
Terry D. Hinds et al.
OBESITY (2014)
Body Fat Percentage Is a Major Determinant of Total Bilirubin Independently of UGT1A1*28 Polymorphism in Young Obese
Luis Belo et al.
PLOS ONE (2014)
Unconjugated bilirubin, a potent endogenous antioxidant, is decreased in patients with non-alcoholic steatohepatitis and advanced fibrosis
Federico Salomone et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Serum Bilirubin Level Is Inversely Associated With Nonalcoholic Steatohepatitis in Children
Kanika Puri et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2013)
NIKEI: A New Inexpensive and Non-Invasive Scoring System to Exclude Advanced Fibrosis in Patients with NAFLD
Muenevver Demir et al.
PLOS ONE (2013)
The Heme Oxygenase System Rescues Hepatic Deterioration in the Condition of Obesity Co-Morbid with Type-2 Diabetes
Tatiana Ntube Salley et al.
PLOS ONE (2013)
Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?
Y. Yilmaz
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Unconjugated hyperbilirubinemia is inversely associated with non-alcoholic steatohepatitis (NASH)
M. Hjelkrem et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Genetic factors associated with the presence and progression of nonalcoholic fatty liver disease: A narrative review
Ruben Hernaez
GASTROENTEROLOGIA Y HEPATOLOGIA (2012)
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Naga Chalasani et al.
HEPATOLOGY (2012)
Serologic predictors of nonalcoholic steatohepatitis in a population undergoing bariatric surgery
Jacob Chisholm et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2012)
The role of bilubinin diabetes, metabolic syndrome, and cardiovascular diseases
Libor Vitek
FRONTIERS IN PHARMACOLOGY (2012)
Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
Min-Sun Kwak et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2012)
No association of promoter variations of HMOX1 and UGT1A1 genes with liver injury in chronic hepatitis C
Petr Urbanek et al.
ANNALS OF HEPATOLOGY (2011)
Clinical predictors of fibrosis in patients with chronic liver disease
M. Stepanova et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Simultaneous genotyping of microsatellite variations in HMOX1 and UGT1A1 genes using multicolored capillary electrophoresis
Alena Jiraskova et al.
CLINICAL BIOCHEMISTRY (2010)
Serum Bilirubin and Genes Controlling Bilirubin Concentrations as Biomarkers for Cardiovascular Disease
Jing-Ping Lin et al.
CLINICAL CHEMISTRY (2010)
Variants in the UGT1A1 Gene and the Risk of Pediatric Nonalcoholic Fatty Liver Disease
Yu-Cheng Lin et al.
PEDIATRICS (2009)
Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease
S. A. Harrison et al.
GUT (2008)
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
Paul Angulo et al.
HEPATOLOGY (2007)
Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease
Thierry Poynard et al.
BMC GASTROENTEROLOGY (2006)
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
Richard K. Sterling et al.
HEPATOLOGY (2006)
Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease
V Ratziu et al.
BMC GASTROENTEROLOGY (2006)
Non-alcoholic steatohepatitis: From cell biology to clinical practice
H Cortez-Pinto et al.
JOURNAL OF HEPATOLOGY (2006)
NASH: a mitochondrial disease
D Pessayre et al.
JOURNAL OF HEPATOLOGY (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients
L Malaguarnera et al.
JOURNAL OF HEPATOLOGY (2005)
The role of heme oxygenase-1 promoter polymorphisms in human disease
M Exner et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
CT Wai et al.
HEPATOLOGY (2003)
Inverse relationship between serum bilirubin and atherosclerosis in men:: A meta-analysis of published studies
L Novotny et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2003)
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
G Marchesini et al.
HEPATOLOGY (2003)
In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases
S Seki et al.
JOURNAL OF HEPATOLOGY (2002)
Share Paper
